Sequoia makes partial PathLabs exit
Sequoia Capital India is making a partial exit from its investment in Dr Lal PathLabs, a leading local diagnostics and pathology chain, selling around half of its 30% stake in the business, with a probable deal value of some $25.4 million.
Sequoia made its initial commitment to the company, around $10.6 million, in 2005, and will reportedly seek to exit the rest of its position when Dr Lal PathLabs has its expected IPO within one to two...
More on South Asia
Latest News
Asian GPs slow implementation of ESG policies - survey
Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...
Singapore fintech start-up LXA gets $10m seed round
New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.
India's InCred announces $60m round, claims unicorn status
Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”
Insight leads $50m round for Australia's Roller
Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.